| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |